Lou Ruvo Center for Brain Health

Naples based board-certified health and performance specialists announce formation of personal excellence consultancy GAIN™

Retrieved on: 
Thursday, October 26, 2023
Small Business, Internet, Hardware, Data Management, Technology, Education, Other Consumer, Other Health, Consumer, Other Construction & Property, Construction & Property, Other Communications, Other Policy Issues, Fitness & Nutrition, Marketing, Advertising, Communications, Health, Public Policy, Government, Training, Other Retail, Supermarket, Data Analytics, Other Travel, Travel, Retail, Other Transport, Legal, Insurance, Human Resources, Finance, Supply Chain Management, Search Engine Optimization, Transport, Consulting, Search Engine Marketing, Other Technology, Banking, Blogging, Software, Professional Services, Naturopathy, NSCA, American College, Stetson University, Sport, Physiology, Life, GAIN, Conjugated estrogens, Certification, CSCS, Medical Center, Sociology, Guilt, Growth, Bachelor of Science, Power, Lou Ruvo Center for Brain Health, Neuroscience, University, Nutritionist, Performance, Happiness, Nursing, Dean, Science, Psychology, Western Michigan University

Jennifer and Dean once lived the unsustainable life of success at all costs.

Key Points: 
  • Jennifer and Dean once lived the unsustainable life of success at all costs.
  • They intimately understand the challenges – and the liberation – that comes with recalibrating mind, body, and performance.
  • GAIN creates a completely personalized roadmap to optimal health and peak performance for its clients that suits their unique body, lifestyle, preferences, and goals.
  • Jennifer earned her certification as a Health & Performance Coach through the Institute of Integrative Nutrition of New York and The American Association of Drugless Practitioners.

The MOG Project, Pediatric Neurologist Secure CDC Approval to Adopt ICD-10 Code for Rare Disease MOGAD

Retrieved on: 
Monday, October 2, 2023
Insurance, Optic neuritis, General assembly, Disease, United Nations, Glycoprotein, CHLA, Neuroimmunology, ICD, Lou Ruvo Center for Brain Health, Knowledge Organization (journal), United Nations General Assembly, Centers for Disease Control and Prevention, Research, Brain, Children's Hospital, Multiple sclerosis, CDC, MOGAD, MD, Patient, Physician, Children's Hospital Los Angeles, Immune system, Optic nerve, Stockholm Environment Institute US Center, Transverse myelitis, Diagnosis, Knowledge, Neuromyelitis optica spectrum disorder, Barrow Neurological Institute, International Classification of Diseases, Video game–related health problems, FDA, Acute disseminated encephalomyelitis, WHO, World Health Organization, Medical device

OLNEY, Md., Oct. 2, 2023 /PRNewswire-PRWeb/ -- The MOG Project, a nonprofit organization committed to supporting the research and treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) announced that its Executive Director Julia Lefelar, with support from The MOG Project Executive Board and Children's Hospital Los Angeles (CHLA) Pediatric Neurologist Jonathan Santoro, MD, secured approval to have the US Centers for Disease Control and Prevention (CDC) create an ICD-10 code for MOGAD. As of October 1, 2023, an official code for MOGAD is included in the 10th edition of the International Classification of Diseases (ICD) and Related Health Problems, which is relied upon by physicians and insurance providers to classify diagnoses and advise treatment.

Key Points: 
  • Without a CDC code, MOGAD patients had previously been grouped in with patients with similar diseases like neuromyelitis optica spectrum disorder, optic neuritis, acute disseminated encephalomyelitis, transverse myelitis and even multiple sclerosis.
  • "For the MOGAD community, this CDC code is more than a win for better health outcomes and fewer insurance delays, it gives our rare disease an identity and legitimizes it."
  • "The addition of a MOGAD specific ICD-10 code allows patients to better access the therapies that they need to treat their disease," said Santoro.
  • "Further, it allows for disease monitoring across the country, which will increase knowledge and research on this rare neuroimmunology disorder."

FAU RECEIVES $750,000 PHILANTHROPIC GRANT FOR ALZHEIMER'S DISEASE

Retrieved on: 
Tuesday, September 19, 2023
Florida Atlantic University, Drink, Prevalence, Celsius, FAU, Marcus Foundation, Patient, Faculty, Health, Neurology, Clinical, DeSantis, Dementia, Ageing, Research, Organization, Neurosurgery, DSM-IV codes, Diagnosis, Death, Caregiver, Alternative medicine, Stroke, BOCA, Rehabilitation, Family, Rexall, Lou Ruvo Center for Brain Health, Disorder, Charles E. Schmidt College of Medicine, Physician, Amyloidosis, Harry, Neurological disorder, Psychiatry, Nursing, Pharmaceutical industry, Alzheimer's disease, Medicine

BOCA RATON, Fla., Sept. 19, 2023 /PRNewswire/ -- More than 720,000 Floridians will be living with Alzheimer's disease by 2025. Currently, Florida has the second highest prevalence of Alzheimer's disease in the United States and is the sixth leading cause of death in Floridians 65 and older.

Key Points: 
  • BOCA RATON, Fla., Sept. 19, 2023 /PRNewswire/ -- More than 720,000 Floridians will be living with Alzheimer's disease by 2025.
  • Currently, Florida has the second highest prevalence of Alzheimer's disease in the United States and is the sixth leading cause of death in Floridians 65 and older.
  • This generous grant from the Carl Angus DeSantis Foundation will help our physicians and scientists combat a neurological disorder that currently impacts nearly 55 million people worldwide."
  • The Marcus Institute of Integrative Health at FAU Medicine combines a variety of evidence-based clinical services with the goal of meeting patients' health care needs.

DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™

Retrieved on: 
Wednesday, September 13, 2023
CSE, Marketing, Pharmacy, Scottish Aquaculture Innovation Centre, Brain Age, Lou Ruvo Center for Brain Health, Privacy, Drexel University, PHIPA, MHealth, Hospital, Brain, EEG, HIPAA, Medical device, Medical imaging

TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative artificial intelligence healthcare company, provides a development and commercialization update for CERVAI™, a brain health AI platform.

Key Points: 
  • TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative artificial intelligence healthcare company, provides a development and commercialization update for CERVAI™, a brain health AI platform.
  • A world first, CERVAI™ consists of a Brain Age Estimation and Brain Health Assessment tool.
  • The Brain Health Assessment tool generates clinician-observed measures and a brain health score.
  • Fabio Chianelli, Chairman and CEO of DiagnaMed, commented: “We are in the final stage of development for CERVAI™, our novel brain health AI platform.

Oklahoma State University receives a $120 million gift from T. Boone Pickens Foundation

Retrieved on: 
Tuesday, June 20, 2023
University of Texas Southwestern Medical Center, University, Education, Life, Wilmer Ophthalmological Institute, Oklahoma State University–Stillwater, Health, Research, Monroe Dunaway Anderson, Lou Ruvo Center for Brain Health, Karsten Creek, OSU, Athlete, Alumni, Student, Human Performance, Cowboy, Dream, Johns Hopkins University, Investment, Faculty, Death, Pharmaceutical industry, Nursing

STILLWATER, Okla., June 20, 2023 /PRNewswire/ -- Oklahoma State University will receive a $120 million gift from the T. Boone Pickens Foundation, OSU President Kayse Shrum announced today.

Key Points: 
  • STILLWATER, Okla., June 20, 2023 /PRNewswire/ -- Oklahoma State University will receive a $120 million gift from the T. Boone Pickens Foundation, OSU President Kayse Shrum announced today.
  • "Physical, mental and spiritual health played a big part in Boone's life," said Jay Rosser, T. Boone Pickens Foundation director.
  • The OSU/A&M Board of Regents acknowledged the $120 million gift from the T. Boone Pickens Foundation at its June 16 board meeting.
  • "We want to thank the T. Boone Pickens Foundation for supporting Oklahoma State University in its ongoing pursuit of excellence as one of the nation's premier land-grant universities."

Horizon Therapeutics Chairman, President and CEO Tim Walbert Named the First Recipient of the Global Rare Trailblazer Award by The Sumaira Foundation

Retrieved on: 
Wednesday, June 14, 2023
Autoimmunity, Horizon Therapeutics, Quality of life, Lou Ruvo Center for Brain Health, Research, NMOSD, Multimedia, Science, MOGAD, UCB, Walbert, Patient, TSF, Autoimmune disease, EMBARC, Neuromyelitis optica spectrum disorder, Empathy, Rare, Caregiver, Disease, Award, Inflammation, Pharmaceutical industry, Rocky Mountains, Genentech

BOSTON, June 14, 2023 /PRNewswire/ -- The Sumaira Foundation (TSF), a global patient advocacy organization focused on rare neuroimmune conditions, is delighted to announce Tim Walbert, chairman, president and chief executive officer of Horizon Therapeutics, as TSF's Inaugural Global Rare Trailblazer Award recipient.

Key Points: 
  • BOSTON, June 14, 2023 /PRNewswire/ -- The Sumaira Foundation (TSF), a global patient advocacy organization focused on rare neuroimmune conditions, is delighted to announce Tim Walbert, chairman, president and chief executive officer of Horizon Therapeutics, as TSF's Inaugural Global Rare Trailblazer Award recipient.
  • Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases.
  • Walbert joined Horizon in 2008 as president and chief executive officer and has served as chairman of the company's board of directors since 2010.
  • We couldn't think of a better person to receive TSF's Global Rare Trailblazer Award, nor of a better occasion than our Annual Gala to present the Award."

UK Dementia Research Institute: NEW CAMPAIGN 'WILD & PRECIOUS' LAUNCHES TO CREATE AWARENESS OF HOW DEMENTIA DISPROPORTIONATELY AFFECTS WOMEN

Retrieved on: 
Wednesday, April 5, 2023
Summer, Impact, Life, Museum of Memory and Human Rights, Alzheimer's Research UK, Lou Ruvo Center for Brain Health, Woman, Statistics, Human, Research, Brain, Butterfly, Alzheimer's disease, DRI, Risk, Knowledge, Death, Disease, Residential care, Birth control, Cryptocurrency, Entertainment, Medical imaging, Blockchain, Dementia

LONDON, April 5, 2023 /PRNewswire/ -- A ground-breaking new campaign called 'Wild & Precious' launches this week (5 April) to raise awareness of dementia's impact on women, supported by the UK Dementia Research Institute (UK DRI). The project focuses on the cherished memories from incredible women living with the illness, women who are carers, and women who have experienced the disease via loved ones. These stories are a celebration of life, but also outline the impact dementia has on their lives.

Key Points: 

Cognition Therapeutics Announces New Episode of “Conversations” Podcast: Insights for the Primary Care Physician: Recognizing Dementia with Lewy Bodies

Retrieved on: 
Monday, March 27, 2023
University of Texas Southwestern Medical Center, University, Pittsburgh, Lou Ruvo Center for Brain Health, Pathology, Dementia, DLB, Cognition, Lewy, Alzheimer's disease, Department of Neurology, Xuanwu hospital, Lewy body, Cleveland, Therapy, Function (mathematics), Epidemiology, Neurology, Medical imaging, Pharmaceutical industry

PURCHASE, N.Y., March 27, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”) has released its fourth “Conversations” video podcast, a two-part conversation about dementia with Lewy bodies (DLB) focusing on the overlapping symptoms and pathology of DLB, Alzheimer's and Parkinson's diseases.

Key Points: 
  • PURCHASE, N.Y., March 27, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”) has released its fourth “Conversations” video podcast, a two-part conversation about dementia with Lewy bodies (DLB) focusing on the overlapping symptoms and pathology of DLB, Alzheimer's and Parkinson's diseases.
  • Four neuroscience thought leaders with a wealth of experience in diagnosing and managing dementia share their insights into the nuanced symptoms and signs that help them differentiate DLB from other dementias such as Alzheimer’s disease.
  • Episode 4: “Insights for the Primary Care Physician: Recognizing Dementia with Lewy Bodies” features a conversation between:
    Brendan Kelley, M.D., (moderator) vice chair for clinical operations at the Peter O’Donnell Jr.
  • We’d love to hear your thoughts!

LAGOS RAISES OVER $100K IN ONE NIGHT FOR KEEP MEMORY ALIVE

Retrieved on: 
Wednesday, February 22, 2023
Caviar, Caregiver, Apple Watch, Memory, Jewellery, The Power of Love, Lou Ruvo Center for Brain Health, Gold, Grandparent, Patient, Entrepreneurship, DSM-IV codes, Sale, Research, Cleveland Clinic, Disease, Creative, Collection, Alzheimer's disease

LAS VEGAS, Feb. 22, 2023 /PRNewswire/ -- Master jeweler Steven Lagos delighted guests at Keep Memory Alive's Power of Love® gala, with a limited-edition ceramic Caviar bracelet, especially designed to support Cleveland Clinic Lou Ruvo Center for Brain Health.

Key Points: 
  • In total, LAGOS has raised more than $1 million for Keep Memory Alive to date.
  • "Each year, we look to expand our commitment to this important cause," said LAGOS Founder and Creative Director Steven Lagos.
  • "It was my pleasure to join the LAGOS team at this year's Keep Memory Alive Power of Love® gala," said Thomson.
  • For over 25 years, LAGOS has supported Keep Memory Alive and its efforts to research and care for those in need.

DiagnaMed Holdings Incorporates OpenAI’s ChatGPT into BRAIN AGE™ AI Product Suite

Retrieved on: 
Wednesday, February 1, 2023
Machine learning, Mental health, Education, AI, Digital platform, Lou Ruvo Center for Brain Health, Government budget balance, Sport, Artificial intelligence, BRAIN, Patient, Athlete, CSE, API, Medical imaging

TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), an artificial intelligence-driven digital health company focusing on improving brain health, today announces that it will incorporate OpenAI’s technology, ChatGPT, in its BRAIN AGE™ Artificial Intelligence (“AI”) Product Suite, which already includes a variety of API interfaces to build AI and machine learning functions, to further enhance the Company’s novel Brain Health Digital Platform to assess overall brain health and presence of cognitive impairment in athletes, and those diagnosed with a mental health and neurodegenerative condition.

Key Points: 
  • TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), an artificial intelligence-driven digital health company focusing on improving brain health, today announces that it will incorporate OpenAI’s technology, ChatGPT, in its BRAIN AGE™ Artificial Intelligence (“AI”) Product Suite, which already includes a variety of API interfaces to build AI and machine learning functions, to further enhance the Company’s novel Brain Health Digital Platform to assess overall brain health and presence of cognitive impairment in athletes, and those diagnosed with a mental health and neurodegenerative condition.
  • DiagnaMed’s Brain Health Digital Platform comprises several assessment tools generated rapidly by self-report or clinician-observed measures, each capturing different aspects of brain health to evaluate overall brain health, output a patient risk score, and provide actionable points to develop precision medicine-like, personalized treatment plans and interventions.
  • As part of the BRAIN AGE™ AI Product Suite, the Brain Health Platform will also include unique brain training, games, education, and coaching applications.
  • “Our Brain Health Digital Platform, which is part of our BRAIN AGE™ AI product suite, offers licensed professionals a novel brain health assessment tool, patient risk score, and helpful intervention plans and techniques, incorporating OpentAI’s technology, ChatGPT, with the aim to improve brain health and brain age of patients,” said Fabio Chianelli, Chairman of DiagnaMed.